Department of Surgery, Massachusetts General Hospital, Boston.
Endocrine Unit, Massachusetts General Hospital, Boston.
JAMA Surg. 2017 Sep 1;152(9):878-882. doi: 10.1001/jamasurg.2017.1721.
Primary hyperparathyroidism (pHPT) is a common clinical entity, with approximately 100 000 new cases diagnosed each year in the United States. Most patients with pHPT have a relatively mild form of the disease and present with few if any overt signs or symptoms. This has led to a dilemma regarding which patients should be considered for parathyroid surgery. In this article, we review the established literature on the indications for surgery in asymptomatic pHPT and discuss the most recent consensus conference guidelines.
The reviewed literature suggests that there were improved outcomes among patients with asymptomatic pHPT who underwent curative surgery.
Most patients with pHPT should be considered for parathyroidectomy. More randomized clinical trials are needed to strongly support a surgical recommendation for all asymptomatic patients with pHPT.
原发性甲状旁腺功能亢进症(pHPT)是一种常见的临床病症,在美国每年约有 100000 例新发病例。大多数 pHPT 患者的疾病呈相对较轻的形式,很少出现明显的体征或症状。这导致了一个难题,即应该考虑对哪些患者进行甲状旁腺手术。在本文中,我们回顾了无症状 pHPT 手术适应证的既定文献,并讨论了最近的共识会议指南。
综述文献表明,接受根治性手术的无症状 pHPT 患者的预后有所改善。
大多数 pHPT 患者都应考虑甲状旁腺切除术。需要更多的随机临床试验来有力支持对所有无症状 pHPT 患者进行手术的建议。